Table 1.

Patient demographics and clinical variables

	n Median (range)
Age at radiotherapy	2.5 years (0.3–3.8)
Age at follow-up	9.1 years (5.5–18.0)
Sex
Male	15 (37.5%)
Female	25 (62.5%)
Race
White	37 (92.5%)
Black	1 (2.5%)
Other	2 (5%)
Income	$76K (32–151)
Histology
Ependymoma	22 (55%)
Medulloblastoma	7 (17.5%)
Other	11 (27.5%)
Shunt for hydrocephalus
Yes	13 (32.5%)
No	27 (67.5%)
Gastrostomy tube
Yes	7 (17.5%)
No	33 (82.5%)
Tracheostomy
Yes	2 (5%)
No	38 (95%)
Chemotherapy
Yes	24 (60%)
No	16 (40%)
High-dose or intrathecal chemotherapy
Yes	10 (25%)
No	30 (75%)
Radiation type
Supratentorial involved field	12 (30%)
Infratentorial involved field	23 (57.5%)
Craniospinal Irradiation	5 (12.5%)
Total radiation dose	54 Gy (50.4–57.6)